Report Detail

Request for Sample of this report

Other Global Clinical for CROs Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4705850
    • |
  • 09 June, 2026
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Clinical for CROs market size was valued at US$ 68425 million in 2025 and is forecast to a readjusted size of US$ 89212 million by 2032 with a CAGR of 3.9% during review period.
Clinical CROs, as the name suggests, are contract research organizations that primarily provide technical services during drug clinical trials. Clinical CROs are responsible for clinical trial design, data management, registration and submission, and post-marketing drug safety monitoring. The global market size currently exceeds $65 billion, while the Chinese market exceeds $8 billion.
This report is a detailed and comprehensive analysis for global Clinical for CROs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Clinical for CROs market size and forecasts, in consumption value ($ Million), 2021-2032
Global Clinical for CROs market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Clinical for CROs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Clinical for CROs market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Clinical for CROs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Clinical for CROs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON plc, IQVIA Inc., Thermo Fisher Scientific, Syneos Health, Inc., Fortrea Holdings Inc, Parexel Inc, Medpace, Hangzhou Tigermed Consulting, CMIC Group, PSI CRO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Clinical for CROs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Clinical Trials and Management
Clinical Laboratory Services
Clinical Data Services
Clinical Consulting Services
Others
Market segment by Application
Pharmaceuticals
Biotechnology
Medical Devices
Others
Market segment by players, this report covers
ICON plc
IQVIA Inc.
Thermo Fisher Scientific
Syneos Health, Inc.
Fortrea Holdings Inc
Parexel Inc
Medpace
Hangzhou Tigermed Consulting
CMIC Group
PSI CRO
Ergomed
Caidya
Medelis
Celerion
Pharmaron Beijing
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Clinical for CROs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical for CROs, with revenue, gross margin, and global market share of Clinical for CROs from 2021 to 2026.
Chapter 3, the Clinical for CROs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Clinical for CROs market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical for CROs.
Chapter 13, to describe Clinical for CROs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Clinical for CROs by Type
    • 1.3.1 Overview: Global Clinical for CROs Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Clinical for CROs Consumption Value Market Share by Type in 2025
    • 1.3.3 Clinical Trials and Management
    • 1.3.4 Clinical Laboratory Services
    • 1.3.5 Clinical Data Services
    • 1.3.6 Clinical Consulting Services
    • 1.3.7 Others
  • 1.4 Global Clinical for CROs Market by Application
    • 1.4.1 Overview: Global Clinical for CROs Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceuticals
    • 1.4.3 Biotechnology
    • 1.4.4 Medical Devices
    • 1.4.5 Others
  • 1.5 Global Clinical for CROs Market Size & Forecast
  • 1.6 Global Clinical for CROs Market Size and Forecast by Region
    • 1.6.1 Global Clinical for CROs Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Clinical for CROs Market Size by Region, (2021-2032)
    • 1.6.3 North America Clinical for CROs Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Clinical for CROs Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Clinical for CROs Market Size and Prospect (2021-2032)
    • 1.6.6 South America Clinical for CROs Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Clinical for CROs Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 ICON plc
    • 2.1.1 ICON plc Details
    • 2.1.2 ICON plc Major Business
    • 2.1.3 ICON plc Clinical for CROs Product and Solutions
    • 2.1.4 ICON plc Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 ICON plc Recent Developments and Future Plans
  • 2.2 IQVIA Inc.
    • 2.2.1 IQVIA Inc. Details
    • 2.2.2 IQVIA Inc. Major Business
    • 2.2.3 IQVIA Inc. Clinical for CROs Product and Solutions
    • 2.2.4 IQVIA Inc. Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 IQVIA Inc. Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific Clinical for CROs Product and Solutions
    • 2.3.4 Thermo Fisher Scientific Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.4 Syneos Health, Inc.
    • 2.4.1 Syneos Health, Inc. Details
    • 2.4.2 Syneos Health, Inc. Major Business
    • 2.4.3 Syneos Health, Inc. Clinical for CROs Product and Solutions
    • 2.4.4 Syneos Health, Inc. Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Syneos Health, Inc. Recent Developments and Future Plans
  • 2.5 Fortrea Holdings Inc
    • 2.5.1 Fortrea Holdings Inc Details
    • 2.5.2 Fortrea Holdings Inc Major Business
    • 2.5.3 Fortrea Holdings Inc Clinical for CROs Product and Solutions
    • 2.5.4 Fortrea Holdings Inc Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Fortrea Holdings Inc Recent Developments and Future Plans
  • 2.6 Parexel Inc
    • 2.6.1 Parexel Inc Details
    • 2.6.2 Parexel Inc Major Business
    • 2.6.3 Parexel Inc Clinical for CROs Product and Solutions
    • 2.6.4 Parexel Inc Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Parexel Inc Recent Developments and Future Plans
  • 2.7 Medpace
    • 2.7.1 Medpace Details
    • 2.7.2 Medpace Major Business
    • 2.7.3 Medpace Clinical for CROs Product and Solutions
    • 2.7.4 Medpace Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Medpace Recent Developments and Future Plans
  • 2.8 Hangzhou Tigermed Consulting
    • 2.8.1 Hangzhou Tigermed Consulting Details
    • 2.8.2 Hangzhou Tigermed Consulting Major Business
    • 2.8.3 Hangzhou Tigermed Consulting Clinical for CROs Product and Solutions
    • 2.8.4 Hangzhou Tigermed Consulting Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hangzhou Tigermed Consulting Recent Developments and Future Plans
  • 2.9 CMIC Group
    • 2.9.1 CMIC Group Details
    • 2.9.2 CMIC Group Major Business
    • 2.9.3 CMIC Group Clinical for CROs Product and Solutions
    • 2.9.4 CMIC Group Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CMIC Group Recent Developments and Future Plans
  • 2.10 PSI CRO
    • 2.10.1 PSI CRO Details
    • 2.10.2 PSI CRO Major Business
    • 2.10.3 PSI CRO Clinical for CROs Product and Solutions
    • 2.10.4 PSI CRO Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 PSI CRO Recent Developments and Future Plans
  • 2.11 Ergomed
    • 2.11.1 Ergomed Details
    • 2.11.2 Ergomed Major Business
    • 2.11.3 Ergomed Clinical for CROs Product and Solutions
    • 2.11.4 Ergomed Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Ergomed Recent Developments and Future Plans
  • 2.12 Caidya
    • 2.12.1 Caidya Details
    • 2.12.2 Caidya Major Business
    • 2.12.3 Caidya Clinical for CROs Product and Solutions
    • 2.12.4 Caidya Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Caidya Recent Developments and Future Plans
  • 2.13 Medelis
    • 2.13.1 Medelis Details
    • 2.13.2 Medelis Major Business
    • 2.13.3 Medelis Clinical for CROs Product and Solutions
    • 2.13.4 Medelis Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Medelis Recent Developments and Future Plans
  • 2.14 Celerion
    • 2.14.1 Celerion Details
    • 2.14.2 Celerion Major Business
    • 2.14.3 Celerion Clinical for CROs Product and Solutions
    • 2.14.4 Celerion Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Celerion Recent Developments and Future Plans
  • 2.15 Pharmaron Beijing
    • 2.15.1 Pharmaron Beijing Details
    • 2.15.2 Pharmaron Beijing Major Business
    • 2.15.3 Pharmaron Beijing Clinical for CROs Product and Solutions
    • 2.15.4 Pharmaron Beijing Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Pharmaron Beijing Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Clinical for CROs Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Clinical for CROs by Company Revenue
    • 3.2.2 Top 3 Clinical for CROs Players Market Share in 2025
    • 3.2.3 Top 6 Clinical for CROs Players Market Share in 2025
  • 3.3 Clinical for CROs Market: Overall Company Footprint Analysis
    • 3.3.1 Clinical for CROs Market: Region Footprint
    • 3.3.2 Clinical for CROs Market: Company Product Type Footprint
    • 3.3.3 Clinical for CROs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Clinical for CROs Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Clinical for CROs Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Clinical for CROs Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Clinical for CROs Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Clinical for CROs Consumption Value by Type (2021-2032)
  • 6.2 North America Clinical for CROs Market Size by Application (2021-2032)
  • 6.3 North America Clinical for CROs Market Size by Country
    • 6.3.1 North America Clinical for CROs Consumption Value by Country (2021-2032)
    • 6.3.2 United States Clinical for CROs Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Clinical for CROs Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Clinical for CROs Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Clinical for CROs Consumption Value by Type (2021-2032)
  • 7.2 Europe Clinical for CROs Consumption Value by Application (2021-2032)
  • 7.3 Europe Clinical for CROs Market Size by Country
    • 7.3.1 Europe Clinical for CROs Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Clinical for CROs Market Size and Forecast (2021-2032)
    • 7.3.3 France Clinical for CROs Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Clinical for CROs Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Clinical for CROs Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Clinical for CROs Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Clinical for CROs Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Clinical for CROs Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Clinical for CROs Market Size by Region
    • 8.3.1 Asia-Pacific Clinical for CROs Consumption Value by Region (2021-2032)
    • 8.3.2 China Clinical for CROs Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Clinical for CROs Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Clinical for CROs Market Size and Forecast (2021-2032)
    • 8.3.5 India Clinical for CROs Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Clinical for CROs Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Clinical for CROs Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Clinical for CROs Consumption Value by Type (2021-2032)
  • 9.2 South America Clinical for CROs Consumption Value by Application (2021-2032)
  • 9.3 South America Clinical for CROs Market Size by Country
    • 9.3.1 South America Clinical for CROs Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Clinical for CROs Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Clinical for CROs Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Clinical for CROs Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Clinical for CROs Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Clinical for CROs Market Size by Country
    • 10.3.1 Middle East & Africa Clinical for CROs Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Clinical for CROs Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Clinical for CROs Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Clinical for CROs Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Clinical for CROs Market Drivers
  • 11.2 Clinical for CROs Market Restraints
  • 11.3 Clinical for CROs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Clinical for CROs Industry Chain
  • 12.2 Clinical for CROs Upstream Analysis
  • 12.3 Clinical for CROs Midstream Analysis
  • 12.4 Clinical for CROs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Clinical for CROs. Industry analysis & Market Report on Clinical for CROs is a syndicated market report, published as Global Clinical for CROs Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Clinical for CROs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo